Arrowhead Research | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Agios Pharmaceuticals USD 73K 0 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Arrowhead Research USD 218K 1000 2024-12
Incyte USD 193K 1000 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
Ligand Pharmaceuticals USD 20K 1000 2024-12
Merck USD 1.79B 0 2024-12
Moderna USD 38.6K 100 2024-12
Novartis USD 793M 0 2024-12
Sarepta Therapeutics USD 10K 0 2024-12
TG Therapeutics USD 156K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Xencor USD 703K 2K 2024-12



Arrowhead Research Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.